A subsidiary of a leading U.S. drugmaker is reporting that the net cost of its products has been falling. If that’s true, it would appear that drug middlemen and insurers are driving increases in the overall cost of medicine and in consumers’ out-of-pocket costs at the counter. The report, by Johnson & Johnson subsidiary Janssen […]
You can’t have it both ways. You can’t be a science-driven, public health advocate and support clear threats to best safety practices during a monumental public health crisis. You can’t be for saving lives during a viral pandemic with prudent safeguards and for politicians out to weaken or scrap them altogether. You can’t vigorously oppose […]
